Reduction of Hypoglycemia Across 180 U.S. Hospitals Using eGlycemic Management System® for IV Insulin Therapy with ICU and non-ICU Patients
Diabetes Technology Society (DTS) Virtual Poster Meeting
June 18, 2020
Joseph Aloi, MD, Raymie McFarland, CCGB
Evaluate the broad-scale impact of eGlycemic Management System® (eGMS®)* on incidence of hypoglycemia among ICU and non-ICU patients receiving intravenous (IV) insulin therapy during hospitalization.
Wake Forest School of Medicine (Winston-Salem, NC) conducted a retrospective analysis of 116,917 patients who received IV insulin therapy guided by eGMS® during a hospital admission between 12/10/17 and 12/10/19. Data was coalesced from 180 sites, 590 units, more than 20 specialties and seven primary areas of care, including emergency department, floor (sans obstetrics), intensive care unit, obstetrics, perioperative, procedural and step-down.
Primary endpoints were percentages of blood glucose measurements (BGs) <40 mg/dL and <70 mg/dL. A secondary endpoint was percentage of BGs >250 mg/dL.
*eGlycemic Management System® is a registered trademark of Glytec, LLC on behalf of Aseko, Inc. All Rights Reserved.
Utilization of eGMS® to guide IV insulin therapy during hospitalization was observed to result in low incidence of hypoglycemia across 180 sites, 590 units, more than 20 specialties, seven primary areas of care, 116,917 patients and 5,388,398 BG measurements. As primary endpoints, the overall mean average percentage of BGs <40 mg/dL was 0.0160% and <70 mg/dL was 0.5295%. As a secondary endpoint, the overall mean average percentage of BGs >250 mg/dL (severe hyperglycemia) was 23.2827%.
Data suggests that acute care facilities of all types, sizes and geographic locales can rely on eGMS® to safely and effectively achieve low incidence of hypoglycemia among ICU and non-ICU patients requiring IV insulin therapy during hospitalization, across virtually any area of care and any specialty.
- Aloi J, McFarland R. Reduction of Hypoglycemia Across 180 U.S. Hospitals Using eGlycemic Management System® for IV Insulin Therapy with ICU and non-ICU Patients. DTS Virtual Poster Meeting. June 18, 2020.